ESP Medical Communication is a independent full-service agency providing strategic communications and publication services that Empower Science into Action
There is no better time than the holiday season to thank everyone who has supported ESP to empower science into action.
So, before the holidays, we would like to take a moment and wish all of you Happy Holidays.
#medicalcommunications#medcomms#medicalaffairs
We are getting a new look! You’ll still see our trusted pink & green, but we have given our logo & website a makeover to reflect our mission to improve the lives of patients by empowering the science of a brand into action that change healthcare. Visit https://t.co/WjhmLVRnLR
On #WorldCancerDay 2025, #ESP Medical Communications stands united with people across the globe in the fight against cancer. This year's theme, #UnitedByUnique” places people at the centre of care and their stories at the heart of the conversation.
A First Time Experience at the ISMPP Europe Meeting.
The ESP team were thrilled to exhibit at the ISMPP Europe meeting for the first time and immerse ourselves in the state-of-the-art discussion in this diverse, dedicated and vibrant community.
#ISMPPEurope2025
A First Time Experience at the ISMPP Europe Meeting
The ESP team were thrilled to exhibit at the ISMPP Europe meeting for the first time and immerse ourselves in the state-of-the-art discussion in this diverse, dedicated and vibrant community
#ISMPP#MedicalCommunications#AI
Please join us on Booth E at the 2025 European Meeting of ISMPP. We look forward to the opportunity to introduce ourselves and explore how the ESP team can empower your unique science.
#ISMPPEurope2025, #ESP, #MedComms, #Publications#MedicalWriting
The LAVA® Liquid Embolic Clinical Study has been published & is now available at @JVIRmedia! LAVA® achieved clinical success at 30 days with 94.3% of lesions studied & 95% of patients. 100% of patients showed no major adverse events. Find the study here: https://t.co/iOkxEdWneq
The ESP team celebrated the end of a successful year empowering science into action, relaxing at a country house hotel and spa. We would like to thank our clients and wish all Happy Holidays and a prosperous New Year!
#happyholidays#MedComms#HealthComms
There is no better time than the holiday season to thank everyone who has helped over the last 17 years with our mission to empower science into action that improves patient care.
We would like to wish all a Happy Holiday Season!
#medicalcommunications#medcomms
Let’s unite on World Parkinson’s day to support people impacted by PD to share their spark and end this disease.
ESP is proud to develop medical communications
with a spark that empowers science into actions that improve patient care.
#worldparkinsonsday, #thespark
#InspireInclusion this International Women's Day
Creating an inclusive workplace is key to diversity & success. ESP as a female founded business takes pride in the advancement of our female workforce. For ESP it is important women feel empowered in their role and career.
It has been a long process but glad that this timely resource on continuous stimulation in Parkinson with a gender balanced young and established global researchers is now out !! thanks all @KingsCollegeLon@ampodlewska@MubasherQamar
“We must find time to stop and thank the people who make a difference in our lives.” JF. Kennedy.
ESP believes there is no better time than the holiday season to thank everyone who has helped empower science into action. Read more: https://t.co/A3zJb0Ik2M
#medcomms
'Where are we now? Continuous Dopaminergic Stimulation for Parkinson’s Disease' published by ESP. Edited by Prof's Per Odin, K Ray Chaudhuri, Sten-Magnus Aquilonius, aided by Ulrika Mundt-Petersen, the book is the first from the CDS Academy.
Learn more: https://t.co/RMOamu27AJ
Celebrating over 15 years of Empowering Engaging Events
Over 15 years, ESP MedComms has successfully delivered 100 live+, hybrid and virtual events in 27 countries. Learn more about our remarkable journey: https://t.co/XorGBSz0km
#medcomms#medicalaffairs#eventservices
A Pivotal, Prospective Multicenter US Study of Lava,a Liquid Embolic Agent Used to Treat Peripheral Arterial Hemorrhage - what did the study show? Dr. Bulent Arslan walks us through the results showing that LAVA is effective & well-tolerated when used for the #embolization of arterial hemorrhage in the peripheral vasculature.
#interventionalradiology #IR #embolotherapy #IRads #MedEd #TwittIR #interventionaloncology #IRadres
Happy Holidays from ESP! There is no time more fitting to say ‘Thank you’, and to wish you a Happy Holiday Season and a New Year of health, happiness and prosperity.